Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings-Reference-Cited by-同舟云学术

Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings

Published:2019-10 Issue:4 Volume:6 Page:321-329
ISSN:2214-3882
Container-title:Asian Journal of Urology
language:en
Short-container-title:Asian Journal of Urology

Author:

Beckmann Kerri,O'Callaghan Michael,Vincent Andrew,Cohen Penelope,Borg Martin,Roder David,Evans Sue,Millar Jeremy,Moretti Kim

Funder

Movember Foundation

Publisher

Elsevier BV

Reference41 articles.

1. NCCN clinical proactice guidelines in oncology: prostate cancer;National Comprehensive Cancer Network,2015

2. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D'Amico;J Am Med Assoc,1998

3. The University of California, San Francisco Cancer of the prostate risk assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy;Cooperberg;J Urol,2005

4. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system;Epstein;Am J Surg Pathol,2016

5. Gleason 6 prostate cancer: translating biology into population health;Eggener;J Urol,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Grade group 4 prostate cancer without intraductal carcinoma on biopsy is more likely to be downgraded on prostatectomy than with intraductal carcinoma;Virchows Archiv;2024-01-25

2. Pathological Assessment of Men with Grade Group 2 Prostate Cancer;The World Journal of Men's Health;2024

3. Novel Multiparametric Magnetic Resonance Imaging-Based Deep Learning and Clinical Parameter Integration for the Prediction of Long-Term Biochemical Recurrence-Free Survival in Prostate Cancer after Radical Prostatectomy;Cancers;2023-06-29

4. Evaluation of selective bone scan staging in prostate cancer – external validation of current strategies and decision-curve analysis;Prostate Cancer and Prostatic Diseases;2022-03-14

5. Cost‐effectiveness of multiparametric magnetic resonance imaging and MRI‐guided biopsy in a population‐based prostate cancer screening setting using a micro‐simulation model;Cancer Medicine;2021-05-15